All In Biotech

Drug Trial Radar · NCT07465120

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With Moderate to Severe Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Mar 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

160

Planned (sponsor's estimate)

Start

Mar 20, 2026

Primary completion

Jan 31, 2027

Study completion May 31, 2027

Sponsor

Lead sponsor
Dermavon Holdings LimitedIndustry
Sponsor type
Industry
First posted
Mar 11, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial, aiming to evaluate the efficacy, safety, and tolerability of CMS-D001 in participants with moderate to severe atopic dermatitis, as well as to assess the pharmacokinetic (PK) and pharmacodynamic (PD) characteristics of CMS-D001 and its major metabolites (as applicable) in participants with moderate to severe atopic dermatitis, so as to provide a basis for the dosage of the Phase III confirmatory clinical trial.

Conditions

  • Moderate to Severe Atopic Dermatitis

Interventions

  • CMS-D001 50mgDrug

    CMS-D001 50mg QD

  • CMS-D001 100mgDrug

    CMS-D001 100mg QD

  • CMS-D001 200mgDrug

    CMS-D001 200mg QD

  • PlaceboDrug

    Placebo QD

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants achieving at least 75% improvement in Eczema Area and Severity Index (EASI 75)Time frame: At week 12

Locations

28 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Huairou Hospital

    Beijing, Beijing Municipality, China

  • Beijing Tongren Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • China-Japan Friendship Hospital

    Beijing, Beijing Municipality, China

  • First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, China

  • Southern Medical University Dermatology Hospital

    Guangzhou, Guangdong, China

  • Peking University Shenzhen Hospital

    Shenzhen, Guangdong, China

  • Hainan Provincial Fifth People's Hospital

    Haikou, Hainan, China

  • Hebei Medical University Second Hospital

    Shijiazhuang, Hebei, China

  • Affiliated Hospital of North China University of Science and Technology

    Tangshan, Hebei, China

  • Zhengzhou Central Hospital

    Zhengzhou, Henan, China

  • Shiyan People's Hospital

    Shiyan, Hubei, China

  • Wuhan No.1 Hospital

    Wuhan, Hubei, China

  • Suzhou Municipal Hospital

    Suzhou, Jiangsu, China

  • Affiliated Hospital of Jiangsu University

    Zhenjiang, Jiangsu, China

  • Affiliated Central Hospital of Shenyang Medical College

    Shenyang, Liaoning, China

  • Shenyang Hospital of Integrated Traditional Chinese and Western Medicine

    Shenyang, Liaoning, China

  • General Hospital of Ningxia Medical University

    Yinchuan, Ningxia, China

  • Shaanxi Provincial People's Hospital

    Xi'an, Shaanxi, China

  • Affiliated Hospital of Binzhou Medical University

    Binzhou, Shandong, China

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China

  • Shanghai Dermatology Hospital

    Shanghai, Shanghai Municipality, China

  • Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

    Shanghai, Shanghai Municipality, China

  • Sichuan Provincial People's Hospital

    Chengdu, Sichuan, China

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, China

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China

  • Hangzhou No.1 People's Hospital

    Hangzhou, Zhejiang, China

  • Hangzhou Third People's Hospital

    Hangzhou, Zhejiang, China

  • Zhejiang Provincial People's Hospital

    Hangzhou, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.